PTC:NASDAQPTC Inc. Analysis
Data as of 2026-05-19 - not real-time
$146.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
PTC is trading at $146, comfortably above its 20‑day SMA ($140.35) and 50‑day SMA ($143.07) but still well below the 200‑day SMA ($174.24), indicating short‑term strength within a longer‑term bearish backdrop. The MACD histogram is positive (0.82) while the signal line is negative, providing a bullish momentum cue, and RSI sits at 58, showing no overbought pressure. Volume is on an increasing trend, supporting the upside bias. The company delivered 21.7% revenue growth, an impressive 84.7% gross margin and 41.6% operating margin, with trailing EPS of $10.42.
Valuation metrics reveal a PE of 14 versus an industry average of 38, and a DCF‑derived fair value of $259, implying roughly 26% upside from current levels. The stock pays no dividend and has a beta of 0.82, indicating lower systematic risk, though 30‑day volatility is elevated at 33%. Strong fundamentals, attractive valuation and bullish short‑term technical signals together suggest a favorable investment case.
Valuation metrics reveal a PE of 14 versus an industry average of 38, and a DCF‑derived fair value of $259, implying roughly 26% upside from current levels. The stock pays no dividend and has a beta of 0.82, indicating lower systematic risk, though 30‑day volatility is elevated at 33%. Strong fundamentals, attractive valuation and bullish short‑term technical signals together suggest a favorable investment case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price above 20‑day and 50‑day SMAs
- Bullish MACD histogram and increasing volume
- Proximity to resistance level limiting upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high profit margins
- Significant valuation upside vs DCF fair value
- Low PE relative to industry and solid cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic positioning in PLM, IoT and AR markets
- Sustained high gross and operating margins
- Undervalued relative to long‑term fair value despite volatility
Key Metrics & Analysis
Financial Health
Revenue Growth21.70%
Profit Margin41.58%
P/E Ratio14.0
ROE34.40%
ROA11.99%
Debt/Equity35.78
P/B Ratio4.5
Op. Cash Flow$938.6M
Free Cash Flow$986.0M
Industry P/E38.3
Technical Analysis
TrendBearish
RSI58.1
Support$132.77
Resistance$153.98
MA 20$140.35
MA 50$143.07
MA 200$174.24
MACDBullish
VolumeIncreasing
Fear & Greed Index89.68
Valuation
Fair Value$259.38
Target Price$183.89
Upside/Downside25.95%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.82
Volatility33.44%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.